The European Association for Cancer Research is hosting EACR24 in Manchester, UK on July 9-12, 2016.  We’re looking forward to…

We often think of rare diseases as being rare, affecting only a small number of people. When looked at from…

Human Genome Variation Society (HGVS) is hosting a meeting on “Clinical Interpretation of Variants from Next-Generation Sequencing”. The meeting will…

It’s DNA Day! DNA Day marks two significant DNA-related milestones — the 1953 discovery of DNA’s double helix and the…

Part four of our webinar series on liquid biopsies:Circulating cell-free DNA purification, sequencing and data interpretation Identification and monitoring of cancer…

Our hereditary disease solution performs best in terms of clinical accuracy at the Critical Assessment of Genome Interpretation (CAGI) conference….

New, powerful bioinformatics tool: The RNA-Seq Explorer Solution Today we announced our new RNA-Seq Explorer Solution — a powerful bioinformatics…

From IPA and Ingenuity® Variant Analysis™ to Biomedical Genomics Workbench, we’re honored to see that our products are on the…

Circulating tumor cells (CTCs) are tumor cells circulating freely in the peripheral blood of patients. The characterization of CTCs is…

Liquid biopsies show promise for cancer research, but technical challenges remain Preparing for this year’s annual meeting of the American…

Looking back at ACMG 2016 where speakers looked ahead to improved variant analysis Inspiring talks at ACMG We recently attended the…

Recently the Journal of Precision Medicine ran a compelling article by Valentin Barsan, MD, about the increasing relevance of next-generation…